GCP in £6m Fishawack bolt-on

GCP acquired Fishawack in an SBO at the end of March. GCP intends to grow the company organically and through a buy-and-build process. This is the first bolt-on for Fishawack since the buyout.

The acquisition will make Fishawack the largest medical communications company in Switzerland, with more than 40 employees, according to GCP.

The merger will also add to the business's clinical and regulatory writing capabilities and pharmacovigilance work.

Company
Founded in 1997 by CEO Francoise Rampelberg and based in Zofingen, Switzerland, Archimed is an agency that specialises in providing pharmacovigilance support and scientific writing for global pharmaceutical companies.

The company currently employs 24 staff.

People
Simon Jobson is a partner at GCP and a member of Fishawack's board. Richard Shaw and Garrett Curran are partners at GCP. Oliver Dennis is the co-founder of Fishawack.

Advisers
Equity – BDO, Ruth Percival, James Fieldhouse (Corporate finance); Chris Heatlie, Steven Kingham (Financial due diligence); Ward Hadaway, Martin Hulls (Legal).
Debt – Brabners, Andrew O'Mahony (Legal).
Company – Hill Dickinson, Craig Scott, Michael Murphy (Legal); Vischer, David Jenny (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Portfolio management
• Now researching
• Support services
• UK / Ireland
• Switzerland
• Growth Capital Partners (aka Close Growth Capital)